SEC Form 4 · accession 0001257171-17-000021
Ainos, Inc. · AIMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Stephen T Chen
Officer — President, CEO & Chairman · Director · 10% Owner
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 1:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001014763
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 31, 2017 | P | 1,000 | $0.254 | A | 99,872 | I | Spouse |
| Common StockF2 | holding | — | — | — | 39,473 | I | ACTS Biosciences, Inc. | |
| Common StockF3 | holding | — | — | — | 638,801 | I | STC International, Inc. | |
| Common Stock | holding | — | — | — | 2,969,111 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1SPOUSE - VIRGINIA M CHEN IRA
- F2STEPHEN CHEN IS CHAIRMAN AND A BOARD MEMBER OF ACTS BIOSCIENCES, INC.
- F3STEPHEN CHEN IS CHAIRMAN, BOARD MEMBER AND MAJOR SHAREHOLDER OF STC INTERNATIONAL, INC.